Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1080 of 5804
-
Poop pills to treat brain fog in the ICU?
Disease control Recruiting nowDelirium in the intensive care unit (ICU) is a prevalent and serious neurological complication among critically ill patients, with large multicenter studies reporting an incidence of 30% to 80%, particularly in those requiring mechanical ventilation. Delirium is not only associat…
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
AI vs. invasive heart test: which is better for stenting?
Disease control Recruiting nowThe AIM-FFR trial is a prospective, multi-center, open-label, randomized controlled, non-inferiority trial. The current trial will evaluate non-inferiority of MPFFR-guided PCI, compared with invasive FFR-guided PCI in patients with coronary artery disease.
Phase: NA • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can community health workers help kidney patients avoid emergency dialysis?
Disease control Recruiting nowThe overarching goal of this project is to refine and adapt previous work on the NAVIGATE-Kidney project for individuals with CKD. The investigators hypothesize that the multilevel NAVIGATE-Kidney program intervention will reduce the rate of central venous catheter use at KRT sta…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Custom RNA vaccine aims to supercharge cancer immunotherapy
Disease control Recruiting nowThe goal of this phase I trial is to evaluate the toxicity and feasibility of a tumor-specific RNA-NP vaccine in patients with stage IIB-IV melanoma who have evidence of progressive disease by RECIST 1.1 criteria while receiving adjuvant aPD1 therapy, or those who progress within…
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug combo aims to keep myeloma in check after CAR-T
Disease control Recruiting nowThe outcomes in patients with relapsed multiple myeloma refractory to triple-therapy (anti-CD38, immunomodulatory drugs (IMiD) and proteasome inhibitors (PI)) remain poor. These patients are eligible for chimeric antigen receptor T-cells (CAR-T), which rely on redirecting autolog…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for advanced cancer? experimental drug MHB009C enters human trials
Disease control Recruiting nowThis is a first-in-human, open-label, multicenter Phase I/II study of MHB009C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB009C monotherapy.
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New mRNA vaccine targets Epstein-Barr virus in early trial
⭐️ VACCINE ⭐️ Recruiting nowThe main objective of this trial is to evaluate the safety and immunogenicity of mRNA-1189 after intradermal and intramuscular delivery.
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
New implant aims to quiet bladder urgency for years
Disease control Recruiting nowThe purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI
Phase: NA • Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New study aims to stop deadly bleeding in liver patients
Disease control Not yet recruitingThis study aims to evaluate the impact of high-risk factors-such as elevated portal venous pressure, concurrent large extra-luminal vessels, portal vein thrombosis, and prominent portosystemic shunts-on the efficacy of endoscopic therapy. By comparing with interventional treatmen…
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for myeloma: early trial of HDP-101 targets relapsed patients
Disease control Recruiting nowThis study is a 2-part study with a dose-escalation part and a dose-expansion part. The aim of the dose-escalation part is to determine the maximum tolerated dose (MTD) and/or establish the recommended Phase 2 dose (RP2D) in the Chinese population, in order to select the treatmen…
Phase: PHASE1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New chickenpox vaccine shows promise in large Kids' trial
⭐️ VACCINE ⭐️ Recruiting nowThis clinical study aims to evaluate the safety and immune response of MG1111, in healthy children compared to VARIVAX. The study will follow participants for 42 days after receiving two doses, with additional follow-ups for up to 10 years to monitor varicella infection.
Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:09 UTC
-
New drug IDE574 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowIDE574 is a synthetically manufactured small molecule inhibitor that co-targets the lysine acetyltransferase enzymes KAT6 and KAT7. The purpose of this study is to evaluate the safety, preliminary efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of IDE574 as monotherap…
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe purpose of this modular, first trial in human study is to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of ascending dose levels (DLs) of AZD4956 monotherapy and in combination with other anti-cancer agents in particip…
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug aims to slow kidney damage in IgA nephropathy
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, parallel, placebo-controlled study and is being conducted to evaluate the efficacy and safety of HS-10542 capsules for primary IgA nephropathy.
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New insulin system aims to simplify diabetes management
Disease control Recruiting nowThe purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complication rates provided by the Omnipod 5 Automated Insulin Delivery System (referred t…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Ancient herbs take on radiation mouth pain: new trial launches
Symptom relief Recruiting nowEvaluate the efficacy and safety of traditional Chinese medicine oral liquid and mouthwash in the treatment of radiotherapy induced oral mucositis in patients with head and neck malignancies
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New rehab pathway aims to get back-pain patients back to work sooner
Disease control Recruiting nowThe R³ trial is a multicentre cluster randomized controlled trial evaluating an evidence-based, person-centred rehabilitation pathway for patients undergoing lumbar surgery for radicular pain. The pathway includes structured pre-, peri-, and postoperative rehabilitation, early po…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a spinning chair help heal concussion symptoms?
Symptom relief Recruiting nowThe goal of this study is to evaluate the efficacy of using sensorimotor multi-axis automated rotational therapy (SMART) to help treat post concussion syndrome (PCS) in adults. The investigators hypothesize that patients who include SMART therapy as part of their treatment regim…
Phase: NA • Sponsor: Neuroscience Group • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a zapping cap restore joy in depressed seniors?
Symptom relief Recruiting nowThis project focuses on clinical translational research into personalized transcranial alternating current stimulation (tACS) for treating anhedonia in late-life depression (LLD). Key components include: (1) Optimizing individualized tACS treatment parameters through randomized, …
Phase: NA • Sponsor: Jie Li • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Can your muscles predict a heart attack? new AI study aims to find out
Knowledge-focused Not yet recruitingThis study is designed as a prospective, single-center, observational cohort study (the SMART-SCD Study, full name: Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death), which enrolls high-risk populations meeting the criteria for implantable cardiover…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC